跳至主要内容
临床试验/NCT07284914
NCT07284914进行中(未招募)不适用

Community Interventions for Tackling Antimicrobial Resistance in Ghana

Penn State University1 个研究点 分布在 1 个国家目标入组 285 人开始时间: 2026年6月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
285
试验地点
1
主要终点
Non-prescription antibiotics dispensing rate

研究概览

简要总结

This research project aims to test the effect of two interventions targeted to community pharmacies in the Greater Accra region, Ghana, on antibiotics dispensing rates. The general goal is to inform the design of future policies to address the rising threat of antimicrobial resistance.

详细描述

Interventions that discourage community pharmacies from providing antibiotics without proper diagnosis and a physician's prescription are critically needed in low- and middle-income countries in order to address the rising threat of antimicrobial resistance. In this study, we will test the effect of two interventions targeted to community pharmacies in the Greater Accra region of Ghana. We will conduct a baseline survey, followed by visits by standardized patients (SPs). We will then implement the interventions (described below) and assess the outcomes again using SPs.

The study has 4 key objectives:

Objective 1. Assess the effect of two behavioral interventions targeted to community pharmacies on antibiotics dispensing rates. We randomly assign 285 pharmacies in Greater Accra 1:1:1 into one of three arms: 1) Control, 2) Individualized Feedback, and 3) Legal Reminder. In the Individualized Feedback arm, we use information from the first visits to provide customized feedback to the pharmacies. In the Legal Reminder arm, we provide a letter from the Ghana authorities emphasizing that providing antibiotics without a physician prescription is against the law.

Objective 2. Assess the extent of know-do gap in antibiotics dispensing behavior among community pharmacies. We compare self-reported data from a baseline survey and the one obtained from SP visits to assess the gap between what the pharmacies know and what they do in practice.

Objective 3. Examine the effect of reduced pressure from patients for antibiotics on pharmacies' dispensing behavior. The two demand variations we will test are the following: 1) Patient asks for a medicine (normal demand pressure), 2) Patient explicitly says that they would prefer not to take antibiotics and mention that they do not have a physician prescription and that their condition appears to be viral (reduced demand pressure).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • for community pharmacies:
  • Operating within the Greater Accra region of Ghana
  • Registered with Ghana Pharmacy Council
  • "Stand-alone", i.e., not affiliated or next to a hospital

排除标准

  • Operating only outside the Greater Accra region of Ghana
  • Not registered with Ghana Pharmacy Council
  • Hospital pharmacy

研究组 & 干预措施

Legal Reminder

Experimental

Pharmacies receive letter from the authorities in Ghana emphasizing that providing antibiotics without a physician prescription is against the law.

干预措施: Legal Reminder (Behavioral)

Control

No Intervention

No intervention

Individualized Feedback

Experimental

Pharmacies receive customized feedback on their antibiotics dispensing behavior.

干预措施: Individualized Feedback (Behavioral)

结局指标

主要结局

Non-prescription antibiotics dispensing rate

时间窗: From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.

Whether the pharmacy dispenses antibiotics without prescription in scenarios not requiring them

次要结局

  • Out-of-pocket costs to patients(From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.)
  • Referral to a physician(From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.)
  • Interaction time(From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.)
  • History taking(From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.)
  • Watch or reserve antibiotics(From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yubraj Acharya, Ph.D.

Associate Professor

Penn State University

研究点 (1)

Loading locations...

相似试验

招募中
不适用
Community-based Actions to Tackle the Problem of Antibiotic Resistance
CTRI/2023/02/050054Indian Council of Medical Research
尚未招募
不适用
Improving the management of sleep disorders in the communitySleep disordersSleep-related symptomsPublic Health - Health service research
ACTRN12612000825853Zaswiza Mohamad Noor110
已完成
Unknown
Intervention to improve antibiotic use in the communityAntibiotic prescription and antibiotic dispensation by health professionals
ISRCTN11636045Instituto de Salud Carlos III627
进行中(未招募)
不适用
A community pharmacy based investigation in the self-medication areaEfficacy and safety of Sinutab® [Paracetamol (500mg) and Pseudoephedrine (30mg)] on subjects with nasal congestion accompanied by headache in the setting of a common coldThe medical rationale = to investigate this combination drug in the symptomatic relief of common cold with nasal symptoms. The reduction of symptom severity may allow subjects receiving active medication to return to work or school earlier than those receiving placebo. To study the drug in it’s ‘natural environment’, community pharmacists will function as local investigators. They will include subjects with early (= 48 hours) cold symptoms of blocked nose with headache.
EUCTR2006-000058-35-BEPfizer Consumer Healthcare Comm. VA/SCA
进行中(未招募)
不适用
A community pharmacy based investigation in the self-medication areaEfficacy and safety of Sinutab® (Paracetamol (500mg)/Pseudoephedrine (30mg)) on subjects with nasal congestion accompanied by headache and/or fever in the setting of a common coldMedical rationale= Investigation of combination drug Sinutab in symptomatic relief of common cold with nasal symptoms. Community pharmacists are considered as local investigators including subjects with early (= 48 hours) cold symptoms of blocked nose with headache and/or fever.
EUCTR2004-001637-41-BEPfizer Consumer Healthcare cva/sca